Becton Dickinson Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Portfolio Pulse from Benzinga Insights
Recent analyst ratings for Becton Dickinson (NYSE:BDX) show a unanimous somewhat bullish sentiment, with 5 analysts rating the stock as such over the past three months. The average 12-month price target is $281.8, down from $297.80, indicating a 5.37% decrease. Analyst actions include both raises and lowers in ratings and price targets, reflecting ongoing market and company performance evaluations. Becton Dickinson, a leading manufacturer and distributor of medical surgical products, shows a positive revenue trend but faces challenges in profitability and efficiency metrics.
February 05, 2024 | 12:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Becton Dickinson's stock has a somewhat bullish outlook from analysts, with a revised average price target suggesting a slight decrease. The company's financial performance shows growth but also highlights areas of concern in profitability and efficiency.
The unanimous somewhat bullish sentiment among analysts, combined with a decrease in the average price target, suggests a cautious optimism towards BDX. The company's positive revenue trend is a strong point, but concerns about profitability and efficiency metrics could temper short-term stock performance. Analysts' actions, including both raises and lowers in ratings and price targets, indicate ongoing adjustments to their outlook based on the company's performance and market conditions.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100